BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24473788)

  • 1. Post-transplant monitoring of chimerism by lineage-specific analysis.
    Preuner S; Lion T
    Methods Mol Biol; 2014; 1109():271-91. PubMed ID: 24473788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of impending graft rejection and relapse by lineage-specific chimerism analysis.
    Lion T
    Methods Mol Med; 2007; 134():197-216. PubMed ID: 17666752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimerism analysis following nonmyeloablative stem cell transplantation.
    Lion T; Watzinger F
    Methods Mol Med; 2006; 125():275-95. PubMed ID: 16502592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
    Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
    Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
    Chin Med J (Engl); 2012 Jun; 125(11):1952-9. PubMed ID: 22884060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
    Czekalska S; Sacha T; Piatkowska-Jakubas B; Zawada M; Florek I; Cwynar D; Skotnicki AB
    Przegl Lek; 2010; 67(12):1282-91. PubMed ID: 21591354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation.
    Breuer S; Preuner S; Fritsch G; Daxberger H; Koenig M; Poetschger U; Lawitschka A; Peters C; Mann G; Lion T; Matthes-Martin S
    Leukemia; 2012 Mar; 26(3):509-19. PubMed ID: 21926962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of Chimerism Analysis After Allogeneic Stem Cell Transplantation.
    Clemente I; Goncalo A; Faria C; Dias M; Barbosa I; Mendes C
    Transplant Proc; 2017 May; 49(4):890-892. PubMed ID: 28457419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the purity of isolated cell populations for lineage-specific chimerism monitoring post haematopoietic stem cell transplantation.
    Hanson V; Adams B; Lord J; Barker A; Poulton K; Lee H
    Tissue Antigens; 2013 Oct; 82(4):269-75. PubMed ID: 24461006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimerism analysis following hematopoietic stem cell transplantation.
    Murphy KM
    Methods Mol Biol; 2013; 999():137-49. PubMed ID: 23666695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive patient-specific real-time PCR SNP assay for chimerism monitoring after allogeneic stem cell transplantation.
    Eshel R; Vainas O; Shpringer M; Naparstek E
    Lab Hematol; 2006; 12(1):39-46. PubMed ID: 16513545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
    Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel PG; Niethammer D; Beck J
    Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.
    Huisman C; de Weger RA; de Vries L; Tilanus MG; Verdonck LF
    Bone Marrow Transplant; 2007 Mar; 39(5):285-91. PubMed ID: 17262061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation with amelogenin marker.
    Ghaffari SH; Chahardouli B; Gavamzadeh A; Alimoghaddam K
    Arch Iran Med; 2008 Jan; 11(1):35-41. PubMed ID: 18154421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
    Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.